Tyers Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.54M Buy
17,688
+1,826
+12% +$164K 0.05% 271
2019
Q2
$1.45M Buy
15,862
+7,416
+88% +$628K 0.05% 270
2019
Q1
$728K Buy
8,446
+2,185
+35% +$175K 0.03% 368
2018
Q4
$481K Sell
6,261
-11,294
-64% -$879K 0.02% 416
2018
Q3
$1.35M Buy
17,555
+958
+6% +$70.8K 0.04% 255
2018
Q2
$1.12M Buy
16,597
+1,915
+13% +$132K 0.04% 277
2018
Q1
$1.06M Buy
14,682
+1,669
+13% +$127K 0.04% 262
2017
Q4
$979K Hold
13,013
0.03% 287
2017
Q3
$1M Hold
13,013
0.04% 276
2017
Q2
$973K Hold
13,013
0.04% 285
2017
Q1
$866K Hold
13,013
0.03% 306
2016
Q4
$849K Buy
+13,013
New +$844K 0.04% 279

Other funds holding NVS

Tyers Asset Management's NVS Position: Q3 2019 in Review

Tyers Asset Management increased its Novartis (NVS) stake by 12% in Q3 2019, buying an estimated $164K and bringing the position to 17,688 shares worth $1.54M. The position accounts for 0.05% of the portfolio, ranked #271.

Tyers Asset Management first reported a position in NVS in Q4 2016 and has held it in 12 quarters since. 1,091 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • Tyers Asset Management held 17,688 shares of Novartis worth $1.54M as of Q3 2019.
  • Tyers Asset Management bought 1,826 Novartis shares in Q3 2019, an estimated $164K.
  • Novartis made up 0.05% of Tyers Asset Management's portfolio in Q3 2019, its #271 holding.
  • Tyers Asset Management first reported a position in Novartis in Q4 2016 and has held it in 12 quarters since.
  • 1,091 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.